Which has better valuation and earnings, CELC or HTFL?

Heartflow has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A Heartflow $176.03M 14.11 -$116.79M -$3.11 N/A

Is CELC or HTFL more profitable?

Celcuity has a net margin of 0.00% compared to Heartflow's net margin of -58.42%. Heartflow's return on equity of 0.00% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% Heartflow -58.42% N/A -20.02%

Does the media prefer CELC or HTFL?

In the previous week, Celcuity had 24 more articles in the media than Heartflow. MarketBeat recorded 26 mentions for Celcuity and 2 mentions for Heartflow. Heartflow's average media sentiment score of 0.61 beat Celcuity's score of 0.22 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 6 Very Negative mention(s) Neutral Heartflow 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, HTFL or PACS?

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 14.11 -$116.79M -$3.11 N/A PACS Group $5.43B 1.09 $191.54M $1.56 24.03

Is HTFL or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% PACS Group 4.49% 26.47% 4.36%

Does the media prefer HTFL or PACS?

In the previous week, Heartflow had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Heartflow and 1 mentions for PACS Group. Heartflow's average media sentiment score of 0.61 beat PACS Group's score of 0.00 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, HIMS or HTFL?

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 2.77 $128.37M -$0.09 N/A Heartflow $176.03M 14.11 -$116.79M -$3.11 N/A

Does the media refer more to HIMS or HTFL?

In the previous week, Hims & Hers Health had 19 more articles in the media than Heartflow. MarketBeat recorded 21 mentions for Hims & Hers Health and 2 mentions for Heartflow. Hims & Hers Health's average media sentiment score of 0.84 beat Heartflow's score of 0.61 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 7 Very Positive mention(s) 7 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HTFL or CAI?

In the previous week, Caris Life Sciences had 1 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Caris Life Sciences and 2 mentions for Heartflow. Heartflow's average media sentiment score of 0.61 beat Caris Life Sciences' score of 0.40 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, HTFL or BLLN?

Billiontoone has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 14.11 -$116.79M -$3.11 N/A Billiontoone $354.54M 13.57 $7.45M $0.55 190.16

Is HTFL or BLLN more profitable?

Billiontoone has a net margin of 0.00% compared to Heartflow's net margin of -58.42%. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% Billiontoone N/A N/A N/A

Does the media prefer HTFL or BLLN?

In the previous week, Heartflow and Heartflow both had 2 articles in the media. Billiontoone's average media sentiment score of 1.38 beat Heartflow's score of 0.61 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Heartflow (HTFL) Competitors

$28.80 -0.05 (-0.17%)

Closing price 06/4/2026 03:59 PM Eastern

Extended Trading

$28.87 +0.07 (+0.25%)

As of 05:59 AM Eastern

Compare

HTFL vs. CELC, PACS, HIMS, CAI, and BLLN

Should you buy Heartflow stock or one of its competitors? MarketBeat compares Heartflow with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Heartflow include Celcuity (CELC), PACS Group (PACS), Hims & Hers Health (HIMS), Caris Life Sciences (CAI), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does Heartflow compare to Celcuity?

Celcuity (NASDAQ:CELC) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Celcuity presently has a consensus price target of $152.09, indicating a potential upside of 64.48%. Heartflow has a consensus price target of $37.00, indicating a potential upside of 28.46%. Given Celcuity's stronger consensus rating and higher possible upside, equities analysts clearly believe Celcuity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Heartflow has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Heartflow	$176.03M	14.11	-$116.79M	-$3.11	N/A

In the previous week, Celcuity had 24 more articles in the media than Heartflow. MarketBeat recorded 26 mentions for Celcuity and 2 mentions for Heartflow. Heartflow's average media sentiment score of 0.61 beat Celcuity's score of 0.22 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	6 Very Negative mention(s)	Neutral
Heartflow	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a net margin of 0.00% compared to Heartflow's net margin of -58.42%. Heartflow's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Heartflow	-58.42%	N/A	-20.02%

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Celcuity and Heartflow tied by winning 7 of the 14 factors compared between the two stocks.

How does Heartflow compare to PACS Group?

Heartflow (NASDAQ:HTFL) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.11	-$116.79M	-$3.11	N/A
PACS Group	$5.43B	1.09	$191.54M	$1.56	24.03

In the previous week, Heartflow had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Heartflow and 1 mentions for PACS Group. Heartflow's average media sentiment score of 0.61 beat PACS Group's score of 0.00 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Heartflow currently has a consensus target price of $37.00, suggesting a potential upside of 28.46%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 28.05%. Given Heartflow's higher probable upside, equities analysts plainly believe Heartflow is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Heartflow on 8 of the 13 factors compared between the two stocks.

How does Heartflow compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

In the previous week, Hims & Hers Health had 19 more articles in the media than Heartflow. MarketBeat recorded 21 mentions for Hims & Hers Health and 2 mentions for Heartflow. Hims & Hers Health's average media sentiment score of 0.84 beat Heartflow's score of 0.61 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	7 Very Positive mention(s)	7 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 2.21%. Heartflow has a consensus target price of $37.00, indicating a potential upside of 28.46%. Given Heartflow's stronger consensus rating and higher probable upside, analysts clearly believe Heartflow is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.77	$128.37M	-$0.09	N/A
Heartflow	$176.03M	14.11	-$116.79M	-$3.11	N/A

Hims & Hers Health has a net margin of -0.56% compared to Heartflow's net margin of -58.42%. Hims & Hers Health's return on equity of 6.10% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Heartflow	-58.42%	N/A	-20.02%

Summary

Hims & Hers Health beats Heartflow on 10 of the 15 factors compared between the two stocks.

How does Heartflow compare to Caris Life Sciences?

Heartflow (NASDAQ:HTFL) and Caris Life Sciences (NASDAQ:CAI) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Caris Life Sciences has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.11	-$116.79M	-$3.11	N/A
Caris Life Sciences	$812.03M	6.02	-$68.09M	-$7.61	N/A

In the previous week, Caris Life Sciences had 1 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Caris Life Sciences and 2 mentions for Heartflow. Heartflow's average media sentiment score of 0.61 beat Caris Life Sciences' score of 0.40 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Heartflow presently has a consensus target price of $37.00, suggesting a potential upside of 28.46%. Caris Life Sciences has a consensus target price of $27.56, suggesting a potential upside of 59.47%. Given Caris Life Sciences' higher possible upside, analysts clearly believe Caris Life Sciences is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Caris Life Sciences has a net margin of 3.75% compared to Heartflow's net margin of -58.42%. Caris Life Sciences' return on equity of 98.28% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Caris Life Sciences	3.75%	98.28%	48.87%

Summary

Caris Life Sciences beats Heartflow on 8 of the 12 factors compared between the two stocks.

How does Heartflow compare to Billiontoone?

Heartflow (NASDAQ:HTFL) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

In the previous week, Heartflow and Heartflow both had 2 articles in the media. Billiontoone's average media sentiment score of 1.38 beat Heartflow's score of 0.61 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Heartflow currently has a consensus target price of $37.00, suggesting a potential upside of 28.46%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 19.79%. Given Heartflow's stronger consensus rating and higher probable upside, equities analysts clearly believe Heartflow is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	14.11	-$116.79M	-$3.11	N/A
Billiontoone	$354.54M	13.57	$7.45M	$0.55	190.16

Billiontoone has a net margin of 0.00% compared to Heartflow's net margin of -58.42%.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Billiontoone	N/A	N/A	N/A

Summary

Billiontoone beats Heartflow on 7 of the 10 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Health Information Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.49B	$322.40M	$6.30B	$12.43B
Dividend Yield	N/A	5.59%	2.69%	5.32%
P/E Ratio	-9.26	230.81	23.73	24.34
Price / Sales	14.11	131.33	496.68	95.47
Price / Cash	N/A	47.14	41.39	55.53
Price / Book	8.16	5.55	10.04	6.72
Net Income	-$116.79M	-$22.78M	$3.56B	$337.03M
7 Day Performance	-7.03%	0.45%	-1.01%	-0.16%
1 Month Performance	-3.87%	1.94%	2.21%	3.74%
1 Year Performance	N/A	-9.46%	28.96%	34.34%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	3.8539 of 5 stars	$28.80 -0.2%	$37.00 +28.5%	N/A	$2.49B	$176.03M	N/A	699	Positive News
CELC Celcuity	3.2179 of 5 stars	$130.91 -2.3%	$150.27 +14.8%	+671.9%	$6.38B	N/A	N/A	40	Trending News Analyst Forecast Analyst Revision
PACS PACS Group	4.027 of 5 stars	$38.00 -3.1%	$48.00 +26.3%	+268.9%	$6.01B	$5.29B	24.36	47,455
HIMS Hims & Hers Health	2.5958 of 5 stars	$25.40 +0.8%	$28.70 +13.0%	-47.8%	$5.88B	$2.35B	N/A	2,442
CAI Caris Life Sciences	4.7895 of 5 stars	$16.67 +8.4%	$27.56 +65.3%	N/A	$4.71B	$812.03M	N/A	1,846

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors

HTFL vs. CELC, PACS, HIMS, CAI, and BLLN

How does Heartflow compare to Celcuity?

Summary

How does Heartflow compare to PACS Group?

Summary

How does Heartflow compare to Hims & Hers Health?

Summary

How does Heartflow compare to Caris Life Sciences?

Summary

How does Heartflow compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Heartflow (HTFL) Competitors

HTFL vs. CELC, PACS, HIMS, CAI, and BLLN

How does Heartflow compare to Celcuity?

Do analysts prefer CELC or HTFL?

Which has better valuation and earnings, CELC or HTFL?

Does the media prefer CELC or HTFL?

Is CELC or HTFL more profitable?

Do insiders & institutionals believe in CELC or HTFL?

Summary

How does Heartflow compare to PACS Group?

Which has stronger valuation and earnings, HTFL or PACS?

Does the media prefer HTFL or PACS?

Do analysts recommend HTFL or PACS?

Is HTFL or PACS more profitable?

Summary

How does Heartflow compare to Hims & Hers Health?

Does the media refer more to HIMS or HTFL?

Do analysts rate HIMS or HTFL?

Do institutionals & insiders believe in HIMS or HTFL?

Which has preferable earnings and valuation, HIMS or HTFL?

Is HIMS or HTFL more profitable?

Summary

How does Heartflow compare to Caris Life Sciences?

Which has higher valuation and earnings, HTFL or CAI?

Does the media prefer HTFL or CAI?

Do analysts rate HTFL or CAI?

Is HTFL or CAI more profitable?

Summary

How does Heartflow compare to Billiontoone?

Does the media prefer HTFL or BLLN?

Do analysts recommend HTFL or BLLN?

Which has higher earnings and valuation, HTFL or BLLN?

Is HTFL or BLLN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools